What has been learnt from study of dopamine receptors in Parkinson's disease?

被引：90

作者：

Hurley, M. J. ^{[1
]}

Jenner, P. ^{[1
]}

机构：

[1] Kings Coll London, Neurodegerat Dis Res Grp, Sch Biomed & Hlth Sci, London SE1 1UL, England

来源：

PHARMACOLOGY & THERAPEUTICS | 2006年 / 111卷 / 03期

关键词：

Parkinson's disease; dopamine receptors; dopamine agonists; L-DOPA;

D O I：

10.1016/j.pharmthera.2005.12.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Since the introduction of dopamine replacement therapy using L-3,4-dihydroxyphenyalanine (L-DOPA) to treat Parkinson's disease and the recognition of the problems associated with L-DOPA use, numerous studies have investigated dopamine receptor regulation and function in Parkinson's disease. These studies have provided insight into the pathological process of the disorder and the molecular consequences of chronic dopaminergic treatment, but they have been less successful in identifying new pharmacological targets or treatment regimes that are as effective as L-DOPA at alleviating the symptoms of Parkinson's disease. This review will present a summary of the reported changes in dopamine receptor regulation and function that occur in Parkinson's disease and will discuss their contribution to the current pharmacological management of Parkinson's disease. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：715 / 728

页数：14

共 178 条

[71] Effects of L-DOPA-therapy on dopamine D-2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys [J].

Herrero, MT ;

Augood, SJ ;

Asensi, H ;

Hirsch, EC ;

Agid, Y ;

Obeso, JA ;

Emson, PC .

MOLECULAR BRAIN RESEARCH, 1996, 42 (01) :149-155

[72] EFFECTS OF L-DOPA ON PREPROENKEPHALIN AND PREPROTACHYKININ GENE-EXPRESSION IN THE MPTP-TREATED MONKEY STRIATUM [J].

HERRERO, MT ;

AUGOOD, SJ ;

HIRSCH, EC ;

JAVOYAGID, F ;

LUQUIN, MR ;

AGID, Y ;

OBESO, JA ;

EMSON, PC .

NEUROSCIENCE, 1995, 68 (04) :1189-1198

[73]

HORNYKIE.O, 1973, FED PROC, V32, P183

[74] LOCALIZATION OF MULTIPLE DOPAMINE RECEPTOR SUBTYPE MESSENGER-RNAS IN HUMAN AND MONKEY MOTOR CORTEX AND STRIATUM [J].

HUNTLEY, GW ;

MORRISON, JH ;

PRIKHOZHAN, A ;

SEALFON, SC .

MOLECULAR BRAIN RESEARCH, 1992, 15 (3-4) :181-188

[75] D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain [J].

Hurd, YL ;

Suzuki, M ;

Sedvall, GC .

JOURNAL OF CHEMICAL NEUROANATOMY, 2001, 22 (1-2) :127-137

[76] Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR [J].

Hurley, MJ ;

Mash, DC ;

Jenner, P .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (09) :2668-2672

[77] Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease [J].

Hurley, MJ ;

Mash, DC ;

Jenner, P .

MOLECULAR BRAIN RESEARCH, 2001, 87 (02) :271-279

[78] D3 receptor expression within the basal ganglia is not affected by Parkinson's disease [J].

Hurley, MJ ;

Stubbs, CM ;

Jenner, P ;

Marsden, CD .

NEUROSCIENCE LETTERS, 1996, 214 (2-3) :75-78

[79] PATHOLOGY OF PARKINSONS-DISEASE - CHANGES OTHER THAN THE NIGROSTRIATAL PATHWAY [J].

JELLINGER, KA .

MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1991, 14 (03) :153-197

[80] A novel dopamine agonist for the transdermal treatment of Parkinson's disease [J].

Jenner, P .

NEUROLOGY, 2005, 65 (02) :S3-S5

← 3 4 5 6 7 8 9 10 11 12 →